Reckitt reported largely in line revenue and a marginal bottom-line beat. The segmental performance was similar to that seen in the last couple of quarters: disappointing Health and robust HygieneHome. The company also announced a surprise £5bn write-down in the IFCN business. For FY 20, management expects growth above FY 18 (+0.8%) and a margin contraction of 350bp, thanks to the investment to drive volume growth. We will revise our estimates downwards to factor in the soft FY 20 guida
28 Feb 2020
Weak finish to FY19, Health outperformance remains elusive!
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Weak finish to FY19, Health outperformance remains elusive!
Reckitt Benckiser Group plc (RKT:LON) | 4,160 1164.9 0.7% | Mkt Cap: 29,395m
- Published:
28 Feb 2020 -
Author:
Virendra Chauhan -
Pages:
3
Reckitt reported largely in line revenue and a marginal bottom-line beat. The segmental performance was similar to that seen in the last couple of quarters: disappointing Health and robust HygieneHome. The company also announced a surprise £5bn write-down in the IFCN business. For FY 20, management expects growth above FY 18 (+0.8%) and a margin contraction of 350bp, thanks to the investment to drive volume growth. We will revise our estimates downwards to factor in the soft FY 20 guida